Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Multiple Myeloma × Prochlorperazine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 3 Nausea 3 Breast Neoplasms 2 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Gynecologic Cancer 1 Breast Neoplasms, Male 1

Interventions

Dexamethasone 374 Lenalidomide 236 Cyclophosphamide 222 Bortezomib 210 Melphalan 174 Calcium Dobesilate 146 fludarabine phosphate 93 daratumumab 92 Peripheral Blood Stem Cell Transplantation 87 carfilzomib 79 Filgrastim 79 Thalidomide 75 pomalidomide 73 Whole-Body Irradiation 73 fludarabine 72 Mycophenolic Acid 68 Busulfan 62 Tacrolimus 58 Granulocyte Colony-Stimulating Factor 58 ixazomib 52 dexamethasone acetate 51 Cyclosporine 51 Antilymphocyte Serum 45 dexamethasone 21-phosphate 44 auricularum 40 Etoposide 35 Radiotherapy 34 Stem Cell Transplantation 33 isatuximab 30 Bendamustine Hydrochloride 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05013437 2024-04-02

AHCT

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡